Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Depreciation and Depletion (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Depreciation and Depletion for 3 consecutive years, with -$65.9 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion changed 0.13% to -$65.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $143.0 billion through Dec 2025, up 38.83% year-over-year, with the annual reading at $143.0 billion for FY2025, 38.83% up from the prior year.
  • Depreciation and Depletion hit -$65.9 million in Q4 2025 for Incannex Healthcare, down from $66.0 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $143.0 billion in Q2 2025 to a low of -$66.0 million in Q4 2024.
  • Historically, Depreciation and Depletion has averaged $27.3 billion across 3 years, with a median of $12.0 million in 2023.
  • Biggest YoY gain for Depreciation and Depletion was 449.43% in 2024; the steepest drop was 264036.0% in 2024.
  • Year by year, Depreciation and Depletion stood at $25000.0 in 2023, then tumbled by 264036.0% to -$66.0 million in 2024, then increased by 0.13% to -$65.9 million in 2025.
  • Business Quant data shows Depreciation and Depletion for IXHL at -$65.9 million in Q4 2025, $66.0 million in Q3 2025, and $143.0 billion in Q2 2025.